Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide Post author: Post published:January 4, 2024 Post category:uncategorized The global prevalence and regional differences in the intention to receive the monkeypox. You Might Also Like MicroRNA panels show promise for improving prostate cancer diagnosis September 2, 2025 MHRA receives £1.8 million to boost antimicrobial innovation and diagnostics May 20, 2024 High-dose curcumin fails to produce lasting gut microbiome changes in IBD patients March 2, 2026